Type
Business expansion
Country
Slovenia
Region
Slovenija; Jugovzhodna Slovenija;
Location of affected unit(s)
Novo Mesto
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.10 - Manufacture of basic pharmaceutical products

200 jobs
Number of planned job creations
Job creation
Announcement Date
4 November 2015
Employment effect (start)
4 November 2015
Foreseen end date
31 October 2016

Description

The Slovenian company Krka is one of the leading producers of generic pharmaceuticals. On 4 November 2015 Krka officially opened in Novo Mesto a new plant, Notol 2, for the production of solid dosage form medicines. The investment, which overall is worth EUR 200 million, is the biggest in the history of the company. The plant, which is currently employing 127 employees, started the production in February and its present capacity (i.e. 1.5 billion of tablets and capsules per year) is only one third of its future full capacity. Several hundred workers will be additionally employed with the progressive expansion of production.

 


Sources

  • 4 November 2015: Delo
  • 4 November 2015: Siol
  • 4 November 2015: KRKA (press release)

Citation

Eurofound (2015), Krka, Business expansion in Slovenia, factsheet number 85280, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/85280.